Pharmacological monitoring and literature analysis of dagliflozin in patients with hypovolemia.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 9, p. 718, doi. 10.5246/jcps.2022.09.061
- By:
- Publication type:
- Article
Works matching IS 10031057 AND DT 2022 AND VI 31 AND IP 9
Results: 7
1
2
Pharmacodynamics of Yuebi Jiazhu Decoction on renal protection of adriamycin nephropathy rats.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 9, p. 711, doi. 10.5246/jcps.2022.09.060
- By:
- Publication type:
- Article
3
Salvianolic acid B alleviates oxidative stress in non-alcoholic fatty liver disease by mediating the SIRT3/FOXO1 signaling pathway.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 9, p. 698, doi. 10.5246/jcps.2022.09.059
- By:
- Publication type:
- Article
4
Dexamethasone up-regulates TNFAIP3 to attenuate inflammatory response with smoke inhalation-induced acute lung injury based on the GEO database.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 9, p. 689, doi. 10.5246/jcps.2022.09.058
- By:
- Publication type:
- Article
5
Recognition of specific types of drug-induced liver injury using random forest algorithm: the importance of individual serum bile acid level.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 9, p. 677, doi. 10.5246/jcps.2022.09.057
- By:
- Publication type:
- Article
6
The pharmacological mechanism underlying the apoptosis of human hepatic stellate cells LX-2 induced by NF-κB inhibitor PDTC.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 9, p. 665, doi. 10.5246/jcps.2022.09.056
- By:
- Publication type:
- Article
7
Fused deposition modeling 3D printed oral famotidine pulsatile release tablets.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 9, p. 657, doi. 10.5246/jcps.2022.09.055
- By:
- Publication type:
- Article